Woodline Partners LP Purchases New Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Woodline Partners LP purchased a new position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 25,126 shares of the company's stock, valued at approximately $2,229,000. Woodline Partners LP owned about 0.17% of U.S. Physical Therapy at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. CBIZ Investment Advisory Services LLC increased its position in U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after acquiring an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at $39,000. Venturi Wealth Management LLC increased its position in U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after acquiring an additional 704 shares during the last quarter. Lazard Asset Management LLC purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at $84,000. Finally, Pacer Advisors Inc. purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at $113,000.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at approximately $588,564.48. This represents a 19.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.00% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on USPH. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. JPMorgan Chase & Co. reduced their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. JMP Securities restated a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Finally, Barrington Research reduced their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $109.00.

U.S. Physical Therapy Stock Performance

USPH traded down $0.27 during midday trading on Friday, reaching $75.34. The company had a trading volume of 17,120 shares, compared to its average volume of 111,304. The company has a market cap of $1.14 billion, a P/E ratio of 80.12, a P/E/G ratio of 3.54 and a beta of 1.44. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The business has a 50-day moving average of $71.99 and a two-hundred day moving average of $82.83. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $102.89.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. The firm had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business's quarterly revenue was up 18.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.51 earnings per share. As a group, equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.39%. The ex-dividend date is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is 82.57%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.